Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002480922 | SCV002786542 | uncertain significance | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2022-01-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001280358 | SCV001467534 | uncertain significance | Familial aplasia of the vermis | 2020-04-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004733230 | SCV005367593 | uncertain significance | RPGRIP1L-related disorder | 2024-07-05 | no assertion criteria provided | clinical testing | The RPGRIP1L c.788G>A variant is predicted to result in the amino acid substitution p.Arg263Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |